A randomized study of interferon-α versus interferon-α and low-dose arabinosyl cytosine in chronic myeloid leukemia
M Baccarani, G Rosti, A de Vivo… - Blood, The Journal …, 2002 - ashpublications.org
Interferon-α (IFN-α) has significantly prolonged survival in chronic myeloid leukemia (CML),
but some patients do not respond and many responses are not durable. To improve the …
but some patients do not respond and many responses are not durable. To improve the …
[PDF][PDF] A randomized study of interferon-versus interferon-and low-dose arabinosyl cytosine in chronic myeloid leukemia
M Baccarani, G Rosti, A de Vivo, F Bonifazi, D Russo… - BLOOD, 2002 - researchgate.net
Interferon-(IFN-) became the treatment of choice for chronic myeloid leukemia (CML) when it
was shown that IFN-was able to induce hematologic and cytogenetic remissions, 1 that …
was shown that IFN-was able to induce hematologic and cytogenetic remissions, 1 that …
A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia
M Baccarani, G Rosti, A de Vivo, F Bonifazi… - …, 2002 - pubmed.ncbi.nlm.nih.gov
Interferon-alpha (IFN-alpha) has significantly prolonged survival in chronic myeloid
leukemia (CML), but some patients do not respond and many responses are not durable. To …
leukemia (CML), but some patients do not respond and many responses are not durable. To …
[引用][C] A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia.
M Baccarani, G Rosti, A DE VIVO, F Bonifazi, D Russo… - BLOOD, 2002 - iris.unito.it
[HTML][HTML] A randomized study of interferon-α versus interferon-α and low-dose arabinosyl cytosine in chronic myeloid leukemia
M Baccarani, G Rosti, A de Vivo, F Bonifazi, D Russo… - Blood, 2002 - Elsevier
Interferon-α (IFN-α) has significantly prolonged survival in chronic myeloid leukemia (CML),
but some patients do not respond and many responses are not durable. To improve the …
but some patients do not respond and many responses are not durable. To improve the …
[引用][C] A randomized study of alphaInterferon vs. alphaInterferon and low dose arabinosyl cytosine in chronic myeloid leukemia
M Baccarani, G Rosti, A DE VIVO, F Bonifazi, D Russo… - BLOOD, 2002 - iris.unibs.it
A randomized study of alphaInterferon vs. alphaInterferon and low dose arabinosyl cytosine
in chronic myeloid leukemia IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo …
in chronic myeloid leukemia IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo …
[引用][C] A randomized study of interferon-α versus interferon-α and low-dose arabinosyl cytosine in chronic myeloid leukemia
M BACCARANI, G ROSTI, G SAGLIO, S TURA… - Blood, 2002 - pascal-francis.inist.fr
A randomized study of interferon-α versus interferon-α and low-dose arabinosyl cytosine in
chronic myeloid leukemia CNRS Inist Pascal-Francis CNRS Pascal and Francis …
chronic myeloid leukemia CNRS Inist Pascal-Francis CNRS Pascal and Francis …
A randomized study of interferon-α versus interferon-α and low-dose arabinosyl cytosine in chronic myeloid leukemia
M Baccarani, G Rosti, A de Vivo, F Bonifazi, D Russo… - BLOOD, 2002 - research.unipg.it
Interferon-α (IFN-α) has significantly prolonged survival in chronic myeloid leukemia (CML),
but some patients do not respond and many responses are not durable. To improve the …
but some patients do not respond and many responses are not durable. To improve the …
A randomized study of interferon-α versus interferon-α and low-dose arabinosyl cytosine in chronic myeloid leukemia
M Baccarani, G Rosti, A de Vivo, F Bonifazi, D Russo… - Blood, 2002 - cir.nii.ac.jp
抄録< jats: p> Interferon-α (IFN-α) has significantly prolonged survival in chronic myeloid
leukemia (CML), but some patients do not respond and many responses are not durable. To …
leukemia (CML), but some patients do not respond and many responses are not durable. To …
A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia.
M Baccarani, G Rosti, A de Vivo, F Bonifazi, D Russo… - Blood, 2002 - europepmc.org
Interferon-alpha (IFN-alpha) has significantly prolonged survival in chronic myeloid
leukemia (CML), but some patients do not respond and many responses are not durable. To …
leukemia (CML), but some patients do not respond and many responses are not durable. To …